Literature DB >> 7593617

IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes.

S Lacraz1, L P Nicod, R Chicheportiche, H G Welgus, J M Dayer.   

Abstract

Human mononuclear phagocytes can modulate the turnover of extracellular matrix by producing metalloproteinases such as 92-kD gelatinase and interstitial collagenase as well as the tissue inhibitor of metalloproteinases (TIMP). We have previously reported that IL-4 and IFN gamma released by lymphocytes suppress metalloproteinase biosynthesis in macrophages without affecting TIMP production (Lacraz, S., L. Nicod, B. C. de Rochementeix, C. Baumberger, J. Dayer, and H. Welgus. 1992. J. Clin. Invest. 90:382-388.; Shapiro, S. D., E. J. Campbell, D. K. Kobayashi, and H. G. Welgus 1990. J. Clin. Invest. 86:1204-1210). Like IL-4, IL-10 is secreted by Th2 lymphocytes and is inhibitory to several macrophage functions. In the present study, IL-10 was tested and compared to IL-2, IL-4, IL-6, and IFN gamma for its capacity to modulate synthesis of 92-kD gelatinase, interstitial collagenase and TIMP in human macrophages and monocytes. We found that IL-10, just like IL-4, inhibited the production of 92-kD gelatinase and blocked LPS-, as well as killed Staphylococcus aureus-induced, interstitial collagenase production. The principal finding of this study, however, was that IL-10, in distinction to IL-4, produced a dose-dependent stimulation in the biosynthesis of TIMP-1. TIMP-2 production was not affected. IL-10 regulated the expression of 92-kD gelatinase and TIMP-1 at the pretranslational level. Furthermore, IL-10 regulation was cell type-specific, as it had no effect on the production of metalloproteinases or TIMP by human fibroblasts. In summary, IL-10 has a potent and unique effect upon tissue macrophages and blood monocytes by enhancing TIMP-1 production while decreasing metalloproteinase biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7593617      PMCID: PMC185881          DOI: 10.1172/JCI118286

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

1.  Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinases-2.

Authors:  E W Howard; E C Bullen; M J Banda
Journal:  J Biol Chem       Date:  1991-07-15       Impact factor: 5.157

2.  Transforming growth factor-beta 1 up-regulates type IV collagenase expression in cultured human keratinocytes.

Authors:  T Salo; J G Lyons; F Rahemtulla; H Birkedal-Hansen; H Larjava
Journal:  J Biol Chem       Date:  1991-06-25       Impact factor: 5.157

3.  Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-beta 1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression.

Authors:  C M Overall; J L Wrana; J Sodek
Journal:  J Biol Chem       Date:  1991-07-25       Impact factor: 5.157

4.  On the structure and chromosome location of the 72- and 92-kDa human type IV collagenase genes.

Authors:  I E Collier; G A Bruns; G I Goldberg; D S Gerhard
Journal:  Genomics       Date:  1991-03       Impact factor: 5.736

5.  Enzyme linked immunosorbent assays (ELISA) for the quantitative determination of human leukocyte collagenase and gelatinase.

Authors:  U Bergmann; J Michaelis; R Oberhoff; V Knäuper; R Beckmann; H Tschesche
Journal:  J Clin Chem Clin Biochem       Date:  1989-06

6.  Immune modulation of metalloproteinase production in human macrophages. Selective pretranslational suppression of interstitial collagenase and stromelysin biosynthesis by interferon-gamma.

Authors:  S D Shapiro; E J Campbell; D K Kobayashi; H G Welgus
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

7.  Characterization of a specific 20- to 25-kD interleukin-1 inhibitor from cultured human lung macrophages.

Authors:  B Galve-de Rochemonteix; L P Nicod; A F Junod; J M Dayer
Journal:  Am J Respir Cell Mol Biol       Date:  1990-10       Impact factor: 6.914

8.  Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI.

Authors:  P Vieira; R de Waal-Malefyt; M N Dang; K E Johnson; R Kastelein; D F Fiorentino; J E deVries; M G Roncarolo; T R Mosmann; K W Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

9.  Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA).

Authors:  M Lotz; P A Guerne
Journal:  J Biol Chem       Date:  1991-02-05       Impact factor: 5.157

10.  Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family.

Authors:  W G Stetler-Stevenson; H C Krutzsch; L A Liotta
Journal:  J Biol Chem       Date:  1989-10-15       Impact factor: 5.157

View more
  73 in total

Review 1.  Immunological evaluation of cytokine and anticytokine immunotherapy in vivo: what have we learnt?

Authors:  C Jorgensen; F Apparailly; J Sany
Journal:  Ann Rheum Dis       Date:  1999-03       Impact factor: 19.103

Review 2.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

3.  Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease.

Authors:  E Louis; C Ribbens; A Godon; D Franchimont; D De Groote; N Hardy; J Boniver; J Belaiche; M Malaise
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

Review 4.  Advances in gene therapy of liver cirrhosis: a review.

Authors:  W J Dai; H C Jiang
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

Review 5.  Genetics and pulmonary medicine. 9. Molecular genetics of chronic obstructive pulmonary disease.

Authors:  P J Barnes
Journal:  Thorax       Date:  1999-03       Impact factor: 9.139

6.  Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin.

Authors:  T Betsuyaku; Y Fukuda; W C Parks; J M Shipley; R M Senior
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

7.  Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trial.

Authors:  Sean van Diepen; Matthew T Roe; Renato D Lopes; Amanda Stebbins; Stefan James; L Kristin Newby; David J Moliterno; Franz-Josef Neumann; Justin A Ezekowitz; Kenneth W Mahaffey; Judith S Hochman; Christian W Hamm; Paul W Armstrong; Pierre Theroux; Christopher B Granger
Journal:  J Thromb Thrombolysis       Date:  2012-07       Impact factor: 2.300

8.  Association of promoter region single nucleotide polymorphisms at positions -819C/T and -592C/A of interleukin 10 gene with ischemic heart disease.

Authors:  Gyeong-Im Yu; Ho-Chan Cho; Yun-Kyeong Cho; Hyoung-Seob Park; Hyuck-Jun Yoon; Hyung-Seop Kim; Chang-Wook Nam; Yoon-Nyun Kim; Kwon-Bae Kim; Eunyoung Ha; Dong-Hoon Shin; Seung-Ho Hur
Journal:  Inflamm Res       Date:  2012-05-17       Impact factor: 4.575

9.  Expression of matrix metalloproteinase-1 and tumor necrosis factor-alpha in ulcerative colitis.

Authors:  Ying-De Wang; Jing-Wei Mao
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

10.  IL-6-mediated induction of matrix metalloproteinase-9 is modulated by JAK-dependent IL-10 expression in macrophages.

Authors:  Poonam Kothari; Roberto Pestana; Rim Mesraoua; Rim Elchaki; K M Faisal Khan; Andrew J Dannenberg; Domenick J Falcone
Journal:  J Immunol       Date:  2013-11-27       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.